REVIEW
Accepted on 24 Feb 2025
MEPED as salvage therapy for relapsed/refractory Hodgkin's lymphoma incorporating edited non-oncogene addiction: mTOR as bottleneck
doi 10.3389/fphar.2025.1553331
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Exploiting Non-Oncogene Addiction for Overcoming Drug Resistance in Metastatic Tumors
Exploiting Non-Oncogene Addiction for Overcoming Drug Resistance in Metastatic Tumors
1,978
Total downloads
7,972
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 25 Jun 2024
NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation
doi 10.3389/fphar.2024.1422369
- 1,429 views
- 1 citation
REVIEW
Published on 20 Feb 2024
The anticancer activity of bile acids in drug discovery and development
doi 10.3389/fphar.2024.1362382
- 4,344 views
- 1 citation
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.